
Nemaura Medical Investor Relations Material
Latest events

Q2 2024
13 Nov, 2023

Q1 2024
14 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nemaura Medical Inc
Access all reports
Nemaura Medical Inc. is a medical technology company focused on the development and commercialization of non-invasive wearable devices for monitoring chronic conditions. Its flagship product is a continuous glucose monitoring system designed to help people with diabetes manage their blood sugar levels without the need for traditional fingerstick tests. Nemaura Medical leverages advanced sensor technology to provide real-time health data, supporting both patients and healthcare providers in managing diabetes and other metabolic disorders. The company is headquartered in Loughborough, England, and its shares are listed on the Nasdaq.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
NMRD
Country
🇺🇸 United States